---
title: "Orinno-backed Sinovay Pharma lists on Shanghai STAR Market as 688837"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299408837.md"
description: "Suzhou Xinnovi Pharma (688837) listed on the Shanghai STAR Market on Sept. 16, with Chengdu High-Tech Orinno Investment Group gaining exposure via a co-investment sub-fund. The company holds a '1+3+N' pipeline: one drug is under NDA review, three are in late-stage trials with CDE breakthrough designations, and an imipenem-cilastatin filing was accepted in July 2025."
datetime: "2026-09-18T06:53:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299408837.md)
  - [en](https://longbridge.com/en/news/299408837.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299408837.md)
generator: "portal-rs"
---

# Orinno-backed Sinovay Pharma lists on Shanghai STAR Market as 688837

-   Suzhou Xinnovi Pharma listed on Shanghai’s STAR Market on Sept. 16 under stock code 688837. \* Chengdu High-Tech Orinno Investment Group gained exposure via a co-investment sub-fund, Chengdu DCP YJ Equity Investment Fund. \* Xinnovi reported a “1+3+N” pipeline; one drug is under NDA review, three are in Phase III or pivotal studies. \* Imipenem-cilastatin injection filing was accepted by China’s CDE in July 2025; approval is expected in 2026. \* Three oncology candidates in late-stage development carry CDE breakthrough designation; approvals are targeted for 2027-2028. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chengdu High-Tech Orinno Investment Group Co Ltd published the original content used to generate this news brief on September 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [688837.CN](https://longbridge.com/en/quote/688837.CN.md)

## Related News & Research

- [Fed officials expect more rate hikes, worry about AI impact on inflation, minutes show](https://longbridge.com/en/news/306011234.md)
- [ANALYSIS-Anthropic listing extends Nasdaq's dominant run against arch-rival NYSE](https://longbridge.com/en/news/306184666.md)
- [Is ServiceNow (NOW) Trading At Too High A Premium For Earnings?](https://longbridge.com/en/news/306039339.md)
- [Cipher Digital Hovers Near Flatline After Anthropic's $83 IPO Pricing](https://longbridge.com/en/news/306148104.md)
- [Meta Platforms (META) Pauses Class C Share Issuance After Delaware Legal Challenge](https://longbridge.com/en/news/306168969.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**